Based on the Ascletis Pharma Inc stock forecast from 0 analysts, the average analyst target price for Ascletis Pharma Inc is not available over the next 12 months. Ascletis Pharma Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Ascletis Pharma Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Ascletis Pharma Inc’s stock price was USD 0.88. Ascletis Pharma Inc’s stock price has changed by +41.18% over the past week, -26.86% over the past month and +333.86% over the last year.
No recent analyst target price found for Ascletis Pharma Inc
No recent average analyst rating found for Ascletis Pharma Inc
Company Overview Ascletis Pharma Inc
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company offers Ritonavir tablet; and ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is headquartered in Hangzhou, the People's Republic of China. Read Less
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company offers Ritonavir tablet; and ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also d...Read More
Frequently Asked Questions About Ascletis Pharma Inc (ASCLF) Stock
Stock Target Advisor's fundamental analysis for Ascletis Pharma Inc's stock is Bearish.
Unfortunately we do not have enough data on ASCLF's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ASCLF's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ASCLF's stock to indicate if its overvalued.
The last closing price of ASCLF's stock was USD 0.88.
The most recent market capitalization for ASCLF is USD 0.66B.
Unfortunately we do not have enough analyst data on ASCLF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Ascletis Pharma Inc's stock.
As per our most recent records Ascletis Pharma Inc has 231 Employees.
Ascletis Pharma Inc's registered address is Building D, Hangzhou, China, 311200.
You can get more information about it from Ascletis Pharma Inc's website at https://www.ascletis.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Ascletis Pharma Inc (ASCLF) Stock
Stock Target Advisor's fundamental analysis for Ascletis Pharma Inc's stock is Bearish.
Unfortunately we do not have enough data on ASCLF's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ASCLF's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ASCLF's stock to indicate if its overvalued.
The last closing price of ASCLF's stock was USD 0.88.
The most recent market capitalization for ASCLF is USD 0.66B.
Unfortunately we do not have enough analyst data on ASCLF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Ascletis Pharma Inc's stock.
As per our most recent records Ascletis Pharma Inc has 231 Employees.
Ascletis Pharma Inc's registered address is Building D, Hangzhou, China, 311200.
You can get more information about it from Ascletis Pharma Inc's website at https://www.ascletis.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ASCLF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
